Results 1 to 10 of about 34,487 (256)

A posteriori diagnosis of DRESS syndrome induced by diazoxide in a patient with an insulinoma: a case report and review of the literature [PDF]

Frontiers in Medicine, 2023
The Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome can be potentially life-threatening. The diagnosis is sometimes difficult since the clinical manifestations may be incomplete or non-specific.
Najoua Lassoued, Najoua Lassoued, Wafa Alaya, Sondos Arfa, Mouna Korbi, Ines Lassoued, Soumaya Ben Amor, Fatma Zaouali, Zayneb Farhat, Jihen Chelly, Mohamed Habib Sfar   +10 more
doaj   +2 more sources

Case Report: Diazoxide-induced diabetic ketoacidosis in a patient with insulinoma [PDF]

Frontiers in Endocrinology
Definitive management of insulinoma is challenging as curative surgery is associated with a considerable risk of morbidity and mortality. The successful long-term use of diazoxide for patients diagnosed with insulinoma has been described, but rarely, the
Run Ting Chin, Jolene Jiayu Kiew, Khek Yu Ho, Doddabele S. Deepak   +3 more
doaj   +2 more sources

Extrapancreatic insulinoma

World Journal of Nuclear Medicine, 2020
A 38-year-old female presented with recurrent episodes of hypoglycemia for 5 years. On 72-h fast test, critical sample biochemistry was suggestive of endogenous hyperinsulinemic hypoglycemia.
Robin Garg, Saba Memon, Virendra Patil, Tushar Bandgar   +3 more
doaj   +3 more sources

Incidence and risk factors for insulinoma diagnosed in dogs under primary veterinary care in the UK [PDF]

Scientific Reports
Insulinoma is the most common pancreatic tumor diagnosed in dogs. This study aimed to report incidence risk, breed predispositions and other demographic risk factors for insulinoma diagnosed in dogs under primary veterinary care in the UK. The VetCompass
Kasper Kraai, Dan G. O’Neill, Lucy J. Davison, Dave C. Brodbelt, Sara Galac, Floryne O. Buishand   +5 more
doaj   +2 more sources

Clinical characteristics and treatment outcomes of patients with insulinoma–a single center's experience of 76 cases over a 10-year period [PDF]

Heliyon
Objective: Insulinoma is a rare pancreatic neuroendocrine neoplasm caused by pancreatic beta cell tumor or beta cell proliferation resulting in excessive insulin secretion.
Wei Li, Yali Cheng, Qingyong Ma, Zheng Wu, Zheng Wang   +4 more
doaj   +2 more sources

A Case of Pediatric Pancreatic Insulinoma Diagnosed 4 Years after the Onset. [PDF]

Surg Case Rep
Kato T, Ibuka S, Sengoku Y, Kawahara T, Matsumoto H, Ozeki M, Ohnishi H, Matsuhashi N.   +7 more
europepmc   +3 more sources

Cystic insulinoma [PDF]

American Journal of Roentgenology, 1984
AC Pogany, RK Kerlan, JH Karam, L Le Quesne, EJ Ring   +4 more
openalex   +3 more sources

Improved detection and localization of insulinoma using small field-of-view diffusion-weighted MRI: A case report. [PDF]

Radiol Case Rep
Nguyen QT, Pham VD, Tran QD, Le QL, Nguyen NC, Le TL.   +5 more
europepmc   +2 more sources

Insulinoma [PDF]

Surgical Clinics of North America, 2009
Insulinoma is a rare neuroendocrine tumor with an incidence of 4 per 1 million persons per year, which may occur as a unifocal sporadic event in patients without an inherited syndrome or as a part of multiple endocrine neoplasia type 1. Key neuroglycopenic and hypoglycemic symptoms in conjunction with biochemical proof establish the diagnosis. Once the
Kimberly, Vanderveen, Clive, Grant
openaire   +4 more sources

Insulinoma - review of characteristics, diagnosis and treatment

Journal of Education, Health and Sport, 2022
Introduction and purpose: Insulinoma is one of a group of pancreatic neuroendocrine neoplasms (NENs). This tumor has its origin in the β cells of the pancreatic islets, which are responsible for the production of insulin.
Klaudia Sapuła, Klaudia Remjasz, Wojciech Siedlecki, Mateusz Fabiś, Julia Kuchnicka, Jakub Aleksandrowicz, Martyna Zielińska   +6 more
doaj   +1 more source